Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury

Open Access

Peer-reviewed

Research Article

Saghir Akhtar ,

* E-mail: Saghir@hsc.edu.kw

Affiliation Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
⨯
Mariam H. M. Yousif,

Affiliation Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
⨯
Bindu Chandrasekhar,

Affiliation Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
⨯
Ibrahim F. Benter

Affiliation Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
⨯

Reader Comments (0)

Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Heart
Is the Subject Area "Heart" applicable to this article?

Thanks for your feedback.
Ischemia
Is the Subject Area "Ischemia" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.
Cardiovascular physiology
Is the Subject Area "Cardiovascular physiology" applicable to this article?

Thanks for your feedback.
EGFR signaling
Is the Subject Area "EGFR signaling" applicable to this article?

Thanks for your feedback.
Reperfusion
Is the Subject Area "Reperfusion" applicable to this article?

Thanks for your feedback.
Signal inhibition
Is the Subject Area "Signal inhibition" applicable to this article?

Thanks for your feedback.